Interrelationships between b-type natriuretic peptides and vitamin D in patients on maintenance peritoneal dialysis

Peritoneal Dialysis International

Volumn 28, Issue 6, 2008, Pages 617-621

  Obineche, Enyioma N ^a   Saadi, Hussain ^a   Benedict, Sheela ^a   Pathan, Javed Y ^a   Frampton, Christopher M ^b   Nicholls, M Gary ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BNP; Renal failure; Renin; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; MIDDLE AGED;

ADULT; AGED; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PERITONEAL DIALYSIS; VITAMIN D;

EID: 60249098786     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800612     Document Type: Article

References (26)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al.; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050-65.
2. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo G, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-15.
3. Naganuma T, Sugimura K, Wada S, Yasumoto R, Sugimura T, Masuda C, et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 2002; 22: 437-44.
4. Dusso A, Brown AJ, Slatopolsky E. Vitamin D and renal failure. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. 2nd ed. San Diego, CA: Elsevier Academic; 2005: 1313-38.
5. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 1999; 55:1019-27.
6. Cannata-Andia JB, Alonso CG. Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant 2002; 17:1875-8.
7. 3. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. 2nd ed. San Diego, CA: Elsevier Academic; 2005: 153-66.
8. Shah N, Bernardini J, Piraino B. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int 2005; 25:362-6.
9. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006; 69:33-43.
10. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16:1115-25.
11. Bidmon H-J, Gutkowska J, Murakami R, Stumpf WE. Vitamin D receptors in heart: effects on atrial natriuretic factor. Experientia 1991; 47:958-62.
12. Wong NL, Halabe A, Wong EF, Sutton RA. The effect of calcitriol on atrial natriuretic factor release from isolated atrium. Metabolism 1991; 40:135-8.
13. 3. J Biol Chem 1994; 269:4934-9.
14. 3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes. Am J Physiol 1995; 268: E1108-E1113.
15. 3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 1996; 97:1577-88.
16. Chen S, Wu J, Hsieh J-C, Whitfield GK, Jurutka PW, Haussler MR, et al. Suppression of ANP gene transcription by liganded vitamin D receptor. Involvement of specific receptor domains. Hypertension 1998; 31:1338-42.
17. Obineche EN, Pathan JY, Fisher S, Prickett TC, Yandle TG, Frampton CM, et al. Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis. Kidney Int 2006; 69:152-6.
18. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993; 76:832-8.
19. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 1997; 47:287-96.
20. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229-38.
21. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol 2005; 288:E125-E132.
22. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl saltsensitive animals. Proc Natl Acad Sci U S A 2007; 104: 16810-15.
23. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33:73-81.
24. Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron 2006; 102:c21-9.
25. Gonzalez EA, Martin KJ. Bone and mineral metabolism in chronic renal failure. In: Johnson RJ, Feehally J, eds. Comprehensive Clinical Nephrology. 2nd ed. London: Mosby; 2003: 873-85.
26. Kates DM, Sherrard DJ, Andress DL. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 1997; 30:809-13.